Prime Medicine
PRME
3.90
+0.40
+11.43%
Prime Medicine
US · PRME
#3501 by market cap
Listed 2022
3.90
+0.40
+11.43%
Live - 5344 symbols - heartbeat 470s ago
· 2026-10-08 09:09
Pre-market
3.85
-1.30%
After-hours
3.88
-0.42%
Overnight
3.94
+1.03%
- Market cap
- 707.37M
- P/E (TTM)i
- -3.71
- P/Bi
- 17.81
- EPSi
- -1.35
- Div yieldi
- 0.00%
- 52W posi
- 31%
Reader sentiment
Are you bullish or bearish on PRME?
Anonymous reader poll. Unscientific, not investment advice.
About Prime Medicine
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.
- Founded
- 2019
- CEO
- Dr. Allan Reine, M.D.
- Employees
- 146
- Headquarters
- Cambridge, Massachusetts, United States of America
- Fiscal year end
- 12-31
- Website
- primemedicine.com
Company profile
- Exchange
- US
- Symbol
- PRME
- Market-cap rank
- #3501
- Listing date
- 2022-10-20
- Market cap
- 707.37M
- Float cap
- 451.31M
- Shares out
- 181.38M
- Float shares
- 115.72M
Sectors & themes
ARK Portfolio
Biotechnology
Quote time 2026-10-08 09:09:33 · For reference only, not investment advice and not tailored to your situation.